TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Interest Expense USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Teva Pharmaceutical Industries Ltd annual Interest Expense history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd annual Interest Expense for 2023 was $1.03 B, a 10.6% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Interest Expense for 2022 was $930 M, a 4.38% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Interest Expense for 2021 was $891 M, a 1.11% decline from 2020.
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.03 B +$99 M +10.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $930 M +$39 M +4.38% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $891 M -$10 M -1.11% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $901 M +$79 M +9.61% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $822 M -$98 M -10.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $920 M +$45 M +5.14% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 $875 M +$329 M +60.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $546 M +$276 M +102% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $270 M -$30 M -10% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $300 M -$14 M -4.46% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $314 M -$41 M -11.5% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $355 M +$121 M +51.7% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $234 M +$32 M +15.8% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 $202 M Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.